This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.94% per year. These returns cover a period from January 1, 1988 through July 6, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View the Zacks #1 Rank List
healthcare: Archive
Profit From the Silver Tsunami: Must-Watch Senior Care & Aging Stocks
by Urmimala Biswas
BSX, ABBV, AMGN and DXCM are tapping into the aging boom with cutting-edge tech, chronic care drugs and senior-focused innovations.
biotechnology biotechs healthcare medical medical-devices pharmaceuticals
UnitedHealth Declines 40.4% YTD: Here's Why it's Still Not a Bargain
by Kaibalya Pravo Dey
UNH shares have plunged YTD, but regulatory risks, cost pressures and earnings downgrades keep it far from a bargain.
healthcare hmo insurance medical
CVS or Cigna: Which Diversified Healthcare Stock Should You Own Now?
by Urmimala Biswas
CVS rallies on turnaround momentum and EPS growth, while CI is a defensive play with stable returns and a focused healthcare strategy.
e-commerce earnings-outlook earnings-report earnings-streak earnings-surprise healthcare retail smart-health
Tempus AI vs. Butterfly: Which AI Health Tech Stock is the Better Buy?
by Urmimala Biswas
BFLY outpaces TEM with stronger upside, leaner valuation, and expanding global reach in AI-powered diagnostics.
artificial-intelligence earnings-outlook earnings-report healthcare medical medical-devices smart-health
UnitedHealth vs. Elevance: Which Healthcare Stock Has More Upside?
by Kaibalya Pravo Dey
ELV outpaces UNH with stronger earnings, leaner costs and clearer guidance, making it the healthcare stock with more upside right now.
healthcare hmo insurance medical
Abbott vs. Medtronic: Which Dividend-Paying MedTech Stock is Better?
by Urmimala Biswas
With both MDT & ABT focusing on their core strengths, the stage is set for a compelling comparison. Let's see which stock is poised for greater upside.
dividend dividend-stocks dividend-yield earnings-outlook earnings-report healthcare medical medical-devices
After 92% YTD Surge, Is Tempus AI a Buy on Trump's Executive Order?
by Urmimala Biswas
President Donald Trump's new executive order aiming to cut U.S. drug prices could benefit Tempus AI.
artificial-intelligence healthcare medical medical-devices smart-health
Should I Buy UnitedHealth Stock Now That it's Half-Off?
by David Bartosiak
UnitedHealth has been in serious trouble as of late. With the stock cut in half, is now the time to buy?
healthcare
CVS Health Stock Rallies 38% in May: Is it a Buy Amid PBM Pressure?
by Urmimala Biswas
CVS' pharmacy segment continues to lead the industry, processing over 1.7 billion prescriptions annually while delivering high medication adherence.
earnings-outlook earnings-report healthcare medical medical-devices retail
Abbott Outpaces Peers Defying Tariff Woes: Is ABT Stock a Smart Buy?
by Urmimala Biswas
Despite trade policy challenges, Abbott's global footprint and 90 manufacturing sites offer flexibility to manage regional risks and reroute supply chains.
earnings-outlook earnings-report healthcare medical medical-devices